Aura Biosciences, Inc.
AURABiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001501796
Revenue FY2025
—
Net Income
$(106.0M)
EPS (Basic)
$-1.76
Net Margin
—
ROE
-77.6%
Total Equity
$137.0M
Shares Out
104M
Aura Biosciences, Inc. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 7 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Matrix Capital Management Company
Matrix Capital Management Company
$46.3M
2.0%
—
Suvretta Capital Management
Suvretta Capital Management
$51.2M
1.1%
+64.8%
Platinum Investment Management
Platinum Investment Management
$0.8M
0.2%
—
Vivo Capital
Vivo Capital
$8.3M
0.1%
NEW
OrbiMed Advisors
OrbiMed Advisors
$23.7M
0.1%
NEW
RA Capital Management
RA Capital Management
$17.8M
0.1%
NEW
Adage Capital Management
Adage Capital Management
$32.9M
0.0%
(4.9%)
Insider Transactions
Reading stored insider transactions…